Biological Drug Market
Biological Drug Market Study by Therapeutic, Monoclonal, and Vaccines for Infectious Diseases, Cancer, Autoimmune Diseases, Rare Diseases, and Others from 2024 to 2034
Analysis of Biological Drug Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Biological Drug Market Outlook (2024 to 2034)
The global biological drug market is estimated to be valued at US$ 421.68 billion in 2024. the market is expected to register a CAGR of 10.2% from 2024 to 2034. The market is projected to reach US$ 1,111.5 billion by 2034. The global rise in chronic diseases is fueling the growth of the biological drug market.
Biological drugs are distinct from synthetic drugs and have carved out a space for themselves in the pharmaceutical industry. The rise of diseases like cancer, autoimmune problems, and blood disorders is necessitating the use of biological drugs. Biological drugs can be used in various treatments, including gene therapy and tissue regeneration, and thus, the scope of the market is vast.
Key Market Growth Drivers
- Manufacturers of biological drugs invest heavily in research and development to come up with new drugs and treatments, which contributes to the constantly evolving nature of the market.
- Biological drugs are finding a market outside of humans, as animals are also administered biological drugs.
- Government initiatives are encouraging the use of biological drugs and are also contributing grants to aid the research in the field of biological drugs.
- Biological drug demand is booming due to the rapidly aging population of the world, with the geriatric population highly prone to chronic diseases.
- With heavy investment in research and development, biomedical technology is improving, paving the way for more advanced treatments.
The launch of new biological drugs is regulated by various regulatory bodies. The rate of approval for new biological drugs is progressing rapidly, contributing to the market’s growth. Thus, companies in the market can launch and sell new products more frequently.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 421.68 billion |
| Forecasted Market Value (2034F) | US$ 1,111.5 billion |
| Global Market Growth Rate (2024 to 2034) | 10.2% CAGR |
| Therapeutical Biological Drug Segment Growth Rate (2024 to 2034) | 10.1% |
| North America Market Share (2024) | 47.2% |
| East Asia Market Share (2024) | 6.2% |
| Key Companies Profiled | Merck & Co., Inc.; Abbott Laboratories; Eli Lilly and Company; Baxter International Inc.; Novartis AG; Pfizer Inc.; Biogen Idec; Bristol-Myers Squibb Company; Amgen Inc.; GlaxoSmithKline plc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Aspects Are Surging the Demand for Biological Drugs?
“Heavy Investments in Research and Development of Drugs from Public and Private Sectors”
The development of novel biological drugs and treatments requires a significant amount of money to be poured into research and development. Research grants are being allocated by governments all over the world for biological drugs, to improve the healthcare facilities in their countries. Private funding is also being sought on an increasing basis in the market. Private institutions are making significant investments in the biological drug industry. Thus, continuous funding enables the launch of new drugs, making way for increased sales.
“Rising Rates of Cancer Around the World Necessitating Increased Use of Biological Drugs”
The incidence of patients afflicted with cancer worldwide is growing. Thus, biological drugs for cancer treatment are in high demand. Public and private healthcare institutions focus on research for developing biological drugs for treating cancer. Thus, cancer-related biological drugs represent significant growth opportunities in the market.
Which Factors Present Challenges to the Expansion of the Biological Drug Market?
“Negative Public Perception about the Side Effects of Biological Drugs and Price Constraints”
Biological drugs have their side effects. In most cases, the side effects of biological drugs are excused as a necessity for the improvement of conditions. However, for some portion of the population, the side effects associated with biological drugs make people apprehensive about the product. The high cost of the drugs also hinders market growth to some extent. The companies in the market thus face challenges.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America accounts for a significant portion of the market, as the affluence of the region makes consumers less hesitant to seek biological drugs. In 2024, the value of the market in North America is estimated to be US$ 199.06 billion, accounting for a market share of 47.2%. The market is expected to progress at a healthy CAGR of 9.7% in North America from 2024 to 2034. The market value is set to reach US$ 503.20 billion by 2034, with a market share of 45.3%.
East Asia is set to be one of the most lucrative regions in the market. Government encouragement and the booming pharmaceutical industry in the region are improving the prospects of the market in East Asia. For 2024, the market value in East Asia is anticipated to be US$ 26.04 billion, with a market share of 6.5%. However, East Asia’s prominence in the market is expected to grow over the forecast period, with the demand progressing at a remarkable CAGR of 10.4%. By 2034, the East Asia market value is forecasted to be US$ 69.88 billion.
What Makes China a Promising Country in the Biological Drug Market?
“Innovation is the Key Factor Making China One of the Leading Countries in the Market”
| Attribute | Details |
|---|---|
| Market Value (2024) | US$ 13.69 billion |
| CAGR (2024 to 2034) | 12% |
China is one of the most promising countries for the market, with an expected 2024 market valuation of US$ 13.69 billion. The market is expected to register an incredible CAGR of 12.0% in China over the forecast period, at the end of which the market value for the country is projected to be US$ 42.65 billion.
China has one of the biggest pharmaceutical industries in the world, and thus, biological drugs have a pathway laid before them for growth. China has also modified the approval processes for biological drugs, allowing for more accurate labeling. With heavy investments into research, innovations in biological drugs are expected to fuel market growth. Thus, the rapid developments in the market keep the demand churning in China.
What is Propelling Sales of Biological Drugs in the South Korea Market?
“Proliferation of Biotech Companies Driving Market Demand”
| Attribute | Details |
|---|---|
| Market Value (2024) | US$ 3.56 billion |
| CAGR (2024 to 2034) | 9.8% |
South Korea is another East Asian country that represents significant potential for market growth. The market is estimated to reach US$ 3.56 billion in 2024. The market is expected to register a promising CAGR of 9.8% over the forecast period. By 2034, the valuation of the biological drug market in South Korea is expected to scale to US$ 9.05 billion.
South Korea is proving to be a fertile ground for biologics and biotech companies. Innovative biotech companies like Cyrus Therapeutics and Gencellmed are ensuring biological drugs remain technically proficient. Thus, South Korea is at the forefront of technological innovation when it comes to biological drugs, ensuring the demand for the product in the country.
Category-wise Insights
Based on the drug type, therapeutic biological drugs are expected to account for 48.9% of the market share in 2024, with a valuation of US$ 206.18 billion. Monoclonal biological drugs are expected to take up the runner-up place, with 35.2% of the market share and a valuation of US$ 148.62 billion.
Why is the Therapeutic Drug Form Highly Preferred by Consumers in the Biological Drug Market?
“Ongoing Popularity of Therapeutic Drugs Ensures the Product Still Rules the Roost in the Biological Drug Market”
| Attribute | Details |
|---|---|
| Market Share (2024) | 48.9% |
The therapeutic biological drug segment is expected to account for 48.9% of the market share by drug type in 2024. The segment’s demand is expected to progress at a CAGR of 10.1% over the forecast period.
Therapeutic drugs are the most common type of synthetic drugs available in the market. Consumers have become used to therapeutic drugs, in part due to their wide availability. Therapeutic drugs are also used in many diseases, ranging from common to severe, and have thus earned the trust of consumers. Therefore, while monoclonal biological drugs are also progressing at a rapid rate, therapeutic drugs remain the dominant drug type.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape in the Biological Drug Market
The biological drug market is fairly fragmented. While the heavy investment required in the development of new drugs favors giant multinational corporations, small-scale players and start-ups are also carving a space for themselves in the market.
Government funding and investments are helping enterprises on a smaller scale to stay competitive and provide competition to big players. For market expansion, companies in the industry are teaming up to exchange technical know-how and collaborate for further advancements in the field of medicine.
Some of the key companies in the market are Merck & Co., Inc., Abbott Laboratories, Eli Lilly and Company, Baxter International Inc., Novartis AG, Pfizer Inc., Biogen Idec, Bristol-Myers Squibb Company, Amgen Inc., and GlaxoSmithKline plc.
Recent Developments in the Biological Drug Market
- In September 2023, Samsung Biologics invested in the South Korean firm AimedBio. The aim of AimedBio is to use artificial intelligence (AI) to analyze patient data.
- In September 2023, US brand Waters Corporation announced solutions that help with the prep and analysis of biological samples. The solutions aim to reduce the time taken for bioprocess development.
- In July 2023, South Korean player Lotte Biologics entered into an agreement with KANAPH Therapeutics to develop an Antibody-Drug Conjugate (ADC) technology platform.
Segmentation of Biological Drug Market Research
-
By Drug Type:
- Therapeutic
- Monoclonal
- Vaccine
-
By Application:
- Infectious Diseases
- Cancer
- Autoimmune Diseases
- Rare Diseases
- Others
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
- 5.1. Monoclonal Antibodies
- 5.2. Vaccines
- 5.3. Recombinant Proteins
- 5.4. Cell Therapy
- 5.5. Gene Therapy
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
- 6.1. Oncology
- 6.2. Autoimmune Diseases
- 6.3. Infectious Diseases
- 6.4. Haematology
- 6.5. Neurology
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 7.1. Hospitals and Clinics
- 7.2. Research Institutes
- 7.3. Homecare Settings
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. South Asia and Pacific
- 8.6. East Asia
- 8.7. Middle East and Africa
- 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Key Countries Market Analysis
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Eli Lilly & Company
- 18.2. Samsung Biologics
- 18.3. F Hoffman La Roche
- 18.4. Lonza
- 18.5. Amgen
- 18.6. Abbvie Inc.
- 18.7. Sanofi
- 18.8. Pfizer Inc.
- 18.9. Merck & Co. Inc
- 18.10. Novo Nordisk A/S
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 17: Global Market Attractiveness by Product Type, 2024 to 2034
Figure 18: Global Market Attractiveness by Application, 2024 to 2034
Figure 19: Global Market Attractiveness by End User, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 37: North America Market Attractiveness by Product Type, 2024 to 2034
Figure 38: North America Market Attractiveness by Application, 2024 to 2034
Figure 39: North America Market Attractiveness by End User, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Product Type, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 59: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Product Type, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 139: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Product Type, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Product Type, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the Leading Drug Type in the Biological Drug Market?
Therapeutic biological drug is the leading drug type in the biological drug market, with an expected market share of 48.9% in 2024.
What is the Sales Outlook for Biological Drugs in 2024?
Sales of biological drugs are estimated to be US$ 421.68 billion in 2024.
What is the Demand Forecast in the Biological Drug Market by 2034?
The demand for biological drugs is projected to reach a market value of US$ 1,111.5 billion by the end of 2034.
What is the Growth Projection of the Biological Drug Market?
Sales of biological drugs are projected to rise at a CAGR of 10.2% through 2034.
What are Some Prominent Biological Drug Companies?
Merck & Co., Inc., Abbott Laboratories, Eli Lilly and Company, and Baxter International Inc. are some of the prominent companies in the market.
Biological Drug Market